US Stock MarketDetailed Quotes

AMPH Amphastar Pharmaceuticals

Watchlist
  • 44.610
  • -0.450-1.00%
Close Nov 15 16:00 ET
  • 44.610
  • 0.0000.00%
Post 17:47 ET
2.14BMarket Cap14.82P/E (TTM)

Amphastar Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-6.80%59.96M
25.83%69.11M
36.92%55.29M
105.76%183.5M
56.73%23.86M
215.75%64.33M
1,851.08%54.92M
-20.45%40.38M
-8.99%89.18M
-62.35%15.23M
Net income from continuing operations
-17.86%40.43M
45.26%37.95M
65.86%43.18M
50.51%137.55M
6.65%36.17M
210.08%49.22M
50.61%26.12M
7.34%26.03M
44.37%91.39M
71.62%33.91M
Operating gains losses
334.48%6.09M
-93.56%164K
-514.66%-4.07M
986.79%7.79M
933.94%6.86M
-295.13%-2.6M
-12.54%2.55M
142.53%982K
93.25%-878K
-48.11%-822K
Depreciation and amortization
6.35%14.43M
101.47%14.15M
88.79%13.96M
47.75%41.78M
88.22%13.79M
85.27%13.57M
2.81%7.02M
8.84%7.4M
6.57%28.28M
15.70%7.33M
Deferred tax
----
----
----
12.79%-13.74M
----
----
----
----
-474.22%-15.75M
----
Other non cash items
-85.79%744K
-23.64%2.44M
3,506.78%2.13M
2,346.14%11.4M
9,610.00%2.91M
2,046.31%5.24M
--3.19M
--59K
112.79%466K
--30K
Change In working capital
-27.56%-7.33M
1.85%8.64M
-3,569.19%-7.27M
24.76%-24.21M
-94.17%-26.75M
14.40%-5.74M
129.54%8.48M
-101.16%-198K
-1,549.26%-32.18M
-216.77%-13.77M
-Change in receivables
58.99%-8.06M
428.82%6.68M
-96.69%-23.2M
-157.46%-26.09M
135.39%4.09M
-645.46%-19.64M
116.24%1.26M
-310.72%-11.8M
32.10%-10.13M
-1,430.46%-11.56M
-Change in inventory
-26.67%-7.31M
-578.74%-7.03M
-3,829.48%-10M
85.32%-1.72M
309.27%4.81M
-4.91%-5.77M
78.14%-1.04M
109.97%268K
-1,033.70%-11.75M
-83.26%1.18M
-Change in prepaid assets
-1,589.76%-10.73M
-16.89%433K
-187.67%-192K
-47.14%-2.73M
11.36%-2.83M
-172.65%-635K
154.73%521K
-84.58%219K
-163.34%-1.85M
-282.32%-3.2M
-Change in payables and accrued expense
208.02%24.65M
341.46%13.73M
318.53%23.08M
1,898.51%13.24M
75.06%-3.39M
2,803.38%8M
-15.97%3.11M
-41.60%5.51M
-120.25%-736K
-1,162.27%-13.58M
-Change in other current liabilities
-5.56%-968K
-7.09%-951K
-9.86%-947K
-13.79%-3.59M
-8.34%-922K
-9.82%-917K
-14.88%-888K
-24.03%-862K
1.38%-3.15M
-27.20%-851K
-Change in other working capital
-137.17%-4.91M
-176.72%-4.23M
-38.19%3.99M
27.14%-3.32M
-300.25%-28.5M
390.25%13.22M
130.33%5.51M
64.52%6.46M
-154.56%-4.56M
158.00%14.23M
Cash from discontinued investing activities
Operating cash flow
-6.80%59.96M
25.83%69.11M
36.92%55.29M
105.76%183.5M
56.73%23.86M
215.75%64.33M
1,851.08%54.92M
-20.45%40.38M
-8.99%89.18M
-62.35%15.23M
Investing cash flow
Cash flow from continuing investing activities
-11.02%-34.59M
86.26%-69.9M
340.60%15.24M
-1,880.40%-649.12M
-44,899.56%-103.05M
-104.17%-31.15M
-6,117.38%-508.58M
30.48%-6.33M
-14.32%-32.78M
98.08%-229K
Net PPE purchase and sale
-35.32%-13.79M
33.24%-6.04M
7.22%-8.79M
-61.63%-38.17M
-49.64%-9.44M
-81.27%-10.19M
-63.40%-9.05M
-54.37%-9.48M
14.00%-23.61M
8.26%-6.31M
Net business purchase and sale
--0
----
----
---506.41M
--0
---5.58M
----
----
--0
--0
Net investment purchase and sale
-1.85%-19.74M
2,888.67%66.74M
664.31%24.03M
-1,259.52%-105.93M
-1,357.46%-91.93M
-104.19%-19.38M
178.88%2.23M
213.01%3.14M
-658.17%-7.79M
304.90%7.31M
Net other investing changes
-126.45%-1.06M
----
----
201.31%1.39M
-36.10%-1.67M
2,855.86%4M
----
----
47.47%-1.37M
18.44%-1.23M
Cash from discontinued investing activities
Investing cash flow
-11.02%-34.59M
86.26%-69.9M
340.60%15.24M
-1,880.40%-649.12M
-44,899.56%-103.05M
-104.17%-31.15M
-6,117.38%-508.58M
30.48%-6.33M
-14.32%-32.78M
98.08%-229K
Financing cash flow
Cash flow from continuing financing activities
-126.34%-22.82M
-102.50%-10.72M
-0.23%-13.58M
1,817.51%454.09M
-191.31%-47.08M
721.72%86.61M
43,169.52%428.11M
-391.48%-13.55M
28.58%-26.44M
-85.86%-16.16M
Net issuance payments of debt
-93.47%9.47M
-101.86%-8.03M
511.57%3.98M
29,653.17%526.34M
-39,081.25%-50.15M
27,863.60%144.93M
73,040.30%432.54M
-79.93%-968K
-105.55%-1.78M
79.12%-128K
Net common stock issuance
30.09%-34.96M
-6,539.06%-8.5M
--0
-45.69%-58.14M
--0
-244.98%-50M
97.91%-128K
-552.16%-8.02M
-38.22%-39.91M
-34.48%-18.07M
Proceeds from stock option exercised by employees
53.43%3.26M
-40.98%5.82M
-279.21%-17.31M
-29.91%10.97M
74.68%3.56M
51.86%2.13M
70.38%9.85M
-170.92%-4.57M
-1.68%15.66M
-64.00%2.04M
Net other financing activities
94.38%-587K
--1K
---252K
-6,061.92%-25.08M
-16,266.67%-491K
-3,213.65%-10.44M
----
----
99.28%-407K
99.03%-3K
Cash from discontinued financing activities
Financing cash flow
-126.34%-22.82M
-102.50%-10.72M
-0.23%-13.58M
1,817.51%454.09M
-191.32%-47.08M
721.73%86.61M
43,169.52%428.11M
-391.48%-13.55M
28.58%-26.44M
-85.86%-16.16M
Net cash flow
Beginning cash position
25.50%189.85M
13.87%201.38M
-7.55%144.53M
23.50%156.33M
72.11%271.04M
-9.08%151.28M
2.31%176.85M
23.50%156.33M
33.95%126.59M
47.39%157.48M
Current changes in cash
-97.86%2.56M
54.95%-11.51M
177.79%56.95M
-138.44%-11.52M
-10,738.45%-126.27M
1,459.14%119.8M
-301.76%-25.55M
-55.72%20.5M
-7.24%29.97M
-105.89%-1.17M
Effect of exchange rate changes
-65.79%-63K
13.64%-19K
-706.25%-97K
-28.18%-282K
-1,352.63%-238K
61.62%-38K
80.18%-22K
155.17%16K
1.35%-220K
139.58%19K
End cash Position
-29.03%192.35M
25.50%189.85M
13.87%201.38M
-7.55%144.53M
-7.55%144.53M
72.11%271.04M
-9.08%151.28M
2.31%176.85M
23.50%156.33M
23.50%156.33M
Free cash flow
-14.72%46.17M
37.49%63.07M
50.45%46.5M
123.09%145.34M
61.75%14.42M
267.01%54.14M
1,557.55%45.87M
-30.75%30.91M
-7.64%65.15M
-73.44%8.92M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -6.80%59.96M25.83%69.11M36.92%55.29M105.76%183.5M56.73%23.86M215.75%64.33M1,851.08%54.92M-20.45%40.38M-8.99%89.18M-62.35%15.23M
Net income from continuing operations -17.86%40.43M45.26%37.95M65.86%43.18M50.51%137.55M6.65%36.17M210.08%49.22M50.61%26.12M7.34%26.03M44.37%91.39M71.62%33.91M
Operating gains losses 334.48%6.09M-93.56%164K-514.66%-4.07M986.79%7.79M933.94%6.86M-295.13%-2.6M-12.54%2.55M142.53%982K93.25%-878K-48.11%-822K
Depreciation and amortization 6.35%14.43M101.47%14.15M88.79%13.96M47.75%41.78M88.22%13.79M85.27%13.57M2.81%7.02M8.84%7.4M6.57%28.28M15.70%7.33M
Deferred tax ------------12.79%-13.74M-----------------474.22%-15.75M----
Other non cash items -85.79%744K-23.64%2.44M3,506.78%2.13M2,346.14%11.4M9,610.00%2.91M2,046.31%5.24M--3.19M--59K112.79%466K--30K
Change In working capital -27.56%-7.33M1.85%8.64M-3,569.19%-7.27M24.76%-24.21M-94.17%-26.75M14.40%-5.74M129.54%8.48M-101.16%-198K-1,549.26%-32.18M-216.77%-13.77M
-Change in receivables 58.99%-8.06M428.82%6.68M-96.69%-23.2M-157.46%-26.09M135.39%4.09M-645.46%-19.64M116.24%1.26M-310.72%-11.8M32.10%-10.13M-1,430.46%-11.56M
-Change in inventory -26.67%-7.31M-578.74%-7.03M-3,829.48%-10M85.32%-1.72M309.27%4.81M-4.91%-5.77M78.14%-1.04M109.97%268K-1,033.70%-11.75M-83.26%1.18M
-Change in prepaid assets -1,589.76%-10.73M-16.89%433K-187.67%-192K-47.14%-2.73M11.36%-2.83M-172.65%-635K154.73%521K-84.58%219K-163.34%-1.85M-282.32%-3.2M
-Change in payables and accrued expense 208.02%24.65M341.46%13.73M318.53%23.08M1,898.51%13.24M75.06%-3.39M2,803.38%8M-15.97%3.11M-41.60%5.51M-120.25%-736K-1,162.27%-13.58M
-Change in other current liabilities -5.56%-968K-7.09%-951K-9.86%-947K-13.79%-3.59M-8.34%-922K-9.82%-917K-14.88%-888K-24.03%-862K1.38%-3.15M-27.20%-851K
-Change in other working capital -137.17%-4.91M-176.72%-4.23M-38.19%3.99M27.14%-3.32M-300.25%-28.5M390.25%13.22M130.33%5.51M64.52%6.46M-154.56%-4.56M158.00%14.23M
Cash from discontinued investing activities
Operating cash flow -6.80%59.96M25.83%69.11M36.92%55.29M105.76%183.5M56.73%23.86M215.75%64.33M1,851.08%54.92M-20.45%40.38M-8.99%89.18M-62.35%15.23M
Investing cash flow
Cash flow from continuing investing activities -11.02%-34.59M86.26%-69.9M340.60%15.24M-1,880.40%-649.12M-44,899.56%-103.05M-104.17%-31.15M-6,117.38%-508.58M30.48%-6.33M-14.32%-32.78M98.08%-229K
Net PPE purchase and sale -35.32%-13.79M33.24%-6.04M7.22%-8.79M-61.63%-38.17M-49.64%-9.44M-81.27%-10.19M-63.40%-9.05M-54.37%-9.48M14.00%-23.61M8.26%-6.31M
Net business purchase and sale --0-----------506.41M--0---5.58M----------0--0
Net investment purchase and sale -1.85%-19.74M2,888.67%66.74M664.31%24.03M-1,259.52%-105.93M-1,357.46%-91.93M-104.19%-19.38M178.88%2.23M213.01%3.14M-658.17%-7.79M304.90%7.31M
Net other investing changes -126.45%-1.06M--------201.31%1.39M-36.10%-1.67M2,855.86%4M--------47.47%-1.37M18.44%-1.23M
Cash from discontinued investing activities
Investing cash flow -11.02%-34.59M86.26%-69.9M340.60%15.24M-1,880.40%-649.12M-44,899.56%-103.05M-104.17%-31.15M-6,117.38%-508.58M30.48%-6.33M-14.32%-32.78M98.08%-229K
Financing cash flow
Cash flow from continuing financing activities -126.34%-22.82M-102.50%-10.72M-0.23%-13.58M1,817.51%454.09M-191.31%-47.08M721.72%86.61M43,169.52%428.11M-391.48%-13.55M28.58%-26.44M-85.86%-16.16M
Net issuance payments of debt -93.47%9.47M-101.86%-8.03M511.57%3.98M29,653.17%526.34M-39,081.25%-50.15M27,863.60%144.93M73,040.30%432.54M-79.93%-968K-105.55%-1.78M79.12%-128K
Net common stock issuance 30.09%-34.96M-6,539.06%-8.5M--0-45.69%-58.14M--0-244.98%-50M97.91%-128K-552.16%-8.02M-38.22%-39.91M-34.48%-18.07M
Proceeds from stock option exercised by employees 53.43%3.26M-40.98%5.82M-279.21%-17.31M-29.91%10.97M74.68%3.56M51.86%2.13M70.38%9.85M-170.92%-4.57M-1.68%15.66M-64.00%2.04M
Net other financing activities 94.38%-587K--1K---252K-6,061.92%-25.08M-16,266.67%-491K-3,213.65%-10.44M--------99.28%-407K99.03%-3K
Cash from discontinued financing activities
Financing cash flow -126.34%-22.82M-102.50%-10.72M-0.23%-13.58M1,817.51%454.09M-191.32%-47.08M721.73%86.61M43,169.52%428.11M-391.48%-13.55M28.58%-26.44M-85.86%-16.16M
Net cash flow
Beginning cash position 25.50%189.85M13.87%201.38M-7.55%144.53M23.50%156.33M72.11%271.04M-9.08%151.28M2.31%176.85M23.50%156.33M33.95%126.59M47.39%157.48M
Current changes in cash -97.86%2.56M54.95%-11.51M177.79%56.95M-138.44%-11.52M-10,738.45%-126.27M1,459.14%119.8M-301.76%-25.55M-55.72%20.5M-7.24%29.97M-105.89%-1.17M
Effect of exchange rate changes -65.79%-63K13.64%-19K-706.25%-97K-28.18%-282K-1,352.63%-238K61.62%-38K80.18%-22K155.17%16K1.35%-220K139.58%19K
End cash Position -29.03%192.35M25.50%189.85M13.87%201.38M-7.55%144.53M-7.55%144.53M72.11%271.04M-9.08%151.28M2.31%176.85M23.50%156.33M23.50%156.33M
Free cash flow -14.72%46.17M37.49%63.07M50.45%46.5M123.09%145.34M61.75%14.42M267.01%54.14M1,557.55%45.87M-30.75%30.91M-7.64%65.15M-73.44%8.92M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Concept Cannabis & Hemp
Cannabis & Hemp
Intraday-1.50%